Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.

WVU Rockefeller Neuroscience Institute continues its mission to advance treatment of brain aneurysms with its participation in the clinical trial of a new device called SEAL. SEAL stands for Saccular ...

WVU Rockefeller Neuroscience Institute continues its mission to advance treatment of brain aneurysms with its participation in the clinical trial of a new device called SEAL. SEAL stands for Saccular ...

WVU Rockefeller Neuroscience Institute are in next phases of their groundbreaking aneurysm device trial. The Seal-It trials ...

In other recent news, Alterity Therapeutics has announced several key developments. The company has completed a Phase 2 clinical trial, marking a significant step in its drug development programs.

The company plans to submit a Biologics License Application (BLA) resubmission for ONS-5010 in early 2025 following the trial's results. Outlook Therapeutics received regulatory approval in the EU ...

United Therapeutics expects the first xenotransplant in this trial to be performed around mid-year 2025. The views and opinions expressed herein are the views and opinions of the author and do not ...

The Samsung Galaxy S25 Ultra is on its way, and there are some great deals on the internet if you look closely and don't go for the first one you find. The S25 Ultra is set to release next week ...

During the Galaxy Unpacked keynote presentation, Samsung officially showcased its next flagship smartphones with the Galaxy S25 series. This includes the Galaxy S25, S25 Plus, and S25 Ultra.

Though it was seven phone generations ago, overstuffing 2017's Galaxy Note 7 infamously led their batteries to catch fire. Samsung could pitch the S25 Edge's thinner size to consumers looking for ...

Jan. 27, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ ... overall design of the Company’s planned Phase 3 AURORA trial for Descartes-08, its lead mRNA cell therapy candidate ...